We aim to invent, develop and commercialize differentiated antibody-based products, which can be utilized in a modular fashion to create unique and tailored therapeutics to transform the treatment of cancer and other serious diseases. 

Our translational research integrates deep insights on patients, diseases, products and antibody modalities to:

• Provide strong biological understanding of our therapeutic products to help drive clinical development decision making
• Generate sophisticated scientific insights by utilizing innovative computational approaches to integrate translational and clinical data
• Understand the biology of our products, and patients, to match the right drug with the right patients
• Bring novel scientific findings back to our discovery portfolio

Our differentiated translational research capabilities, which leverage biomarkers and companion diagnostics, are bringing us closer to delivering antibody therapeutics so that the right medicine reaches the right patient at the right dose.